CAPN5 and meningioma: A 2017 genomic study of meningiomas by Dewan et al. suggested significant intratumoral genetic heterogeneity (in mutations of ADAMTSL3 and CAPN5) in grade II meningiomas that can affect tumor hardness, fibrosity, and adhesiveness [20].